Clinics in Dermatology
Volume 28, Issue 1 , Pages 52-56, January 2010

Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies

Department of Dermatology, Johann Wolfgang Goethe-University, Theodor-Stern-Kai 7, D 60590 Frankfurt am Main, Germany

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0738-081X(09)00087-X

doi:10.1016/j.clindermatol.2009.04.001

Clinics in Dermatology
Volume 28, Issue 1 , Pages 52-56, January 2010

Article Tools